B CELL LYMPHOMA
Clinical trials for B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough lymphoma cases
Disease control Recruiting nowThis study is for people with large B cell lymphoma whose cancer has returned or not responded to initial treatment. Researchers are testing a combination of two drugs, axicabtagene ciloleucel and glofitamab, to see if they can better control the disease. About 40 participants wi…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC
-
New hope for lymphoma patients: drug combo aims for complete remission without chemo
Disease control Recruiting nowThis study tests a two-drug combination (mosunetuzumab and lenalidomide) as the first treatment for adults with follicular or marginal zone lymphoma who have not had prior therapy. The goal is to see how many patients achieve complete remission after 8 cycles. The treatment is ad…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Apr 29, 2026 05:13 UTC
-
New drug combo aims to control tough lymphoma
Disease control Recruiting nowThis study tests whether adding sonrotoclax to the standard drug zanubrutinib helps adults with mantle cell lymphoma that has returned or stopped responding to prior treatments. About 300 participants will receive either the combination or a placebo plus zanubrutinib. The main go…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Apr 29, 2026 05:13 UTC
-
Crushed cancer pill study aims to help kids who Can't swallow tablets
Knowledge-focused Recruiting nowThis study looks at how the body handles venetoclax when the tablet is crushed and mixed into a liquid. It includes children and young adults up to age 39 with blood cancers like leukemia or lymphoma who already take venetoclax this way. The goal is to measure drug levels in the …
Matched conditions: B CELL LYMPHOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC